TAKP34:BVMF
Takeda Pharmaceutical Company
99,07 R$
arrow_upward
+1,33%(+1,30) 1 d.
28. sept., 20:23:55 GMT-3 · BRL
search
Visi simboli
| Simbols | Cena | Izmaiņas | % izmaiņu |
|---|
insights_autoNotiek galveno ieskatu ģenerēšana par šādu tēmu: TAKP34…
Tirgus kapitalizācija
57,04 mljrd.
Vid. apjoms
36,00
Apjoms
0,00
Augstākā 52 ned.
99,07 R$
Zemākā 52 ned.
70,80 R$
Apgrozībā esošās akcijas
1,60 mljrd.
Darbinieku skaits
47 tūkst.
Tirgus kapitalizācija
57,04 mljrd.
Vid. apjoms
36,00
Apjoms
0,00
Augstākā 52 ned.
99,07 R$
Zemākā 52 ned.
70,80 R$
Apgrozībā esošās akcijas
1,60 mljrd.
Darbinieku skaits
47 tūkst.
Ziņas un raksti
No tīmekļa avotiem un ziņu partneriem
TipRanks
·
pirms 5 stundām
Takeda’s GATTEX Safety Survey Update: What Investors Should Watch
Stock Traders Daily
·
pirms 1 dienas
(TAK) Movement Within Algorithmic Entry Frameworks
Profils
The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company. It is the third largest pharmaceutical company in Asia, behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue. The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies and vaccines. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States. As of 2015, Christophe Weber was appointed as the CEO and president of Takeda. In 2026, Julie Kim was noted in a news item as "CEO-elect". Wikipedia
Par “Takeda Pharmaceutical Company”
ĢenerāldirektorsChristophe Weber | Christophe Weber
Darbinieki47 tūkst.
Dibināšanas datums1781. gada 12. jūn.
Galvenais birojs-
Sektors-
Tīmekļa vietnetakeda.com